A small, multi-center cohort study of SBRT in treatment of low-risk prostate cancer

Published reports on the safety and efficacy of extreme hypofactionated radiation therapy (stereotactic body radiation therapy or SBRT, a.k.a. CyberKnife radiation therapy) have, to date, come from just a couple of key centers.

All the different types of external beam radiation therapy for prostate cancer: a good introduction

Over the past 20 years there has been an explosion in the different ways that we use varied types of external beam radiation therapy for the treatment of localized and locally advanced forms of prostate cancer. Where is the newly diagnosed patient able to find a good, basic introduction?

Dose escalation of SBRT in treatment of localized prostate cancer

Most published data on the use of stereotactic body radiation therapy (SBRT; CyberKnife radiation therapy) has been based on  a total radiation dose of 32 to 38 Gy delivered in a series of four or five sessions — as compared to the delivery of more like 75 to 80 Gy using intensity-modulated radiation (IMRT) and [...]

Additional 5-year follow-up data on SBRT for localized prostate cancer

In February this year we reported initial 4- and 5-year follow-up data from two US-based research teams on the use of stereotactic body radiation therapy (SBRT or CyberKnife radiation) as a treatment for prostate cancer. A new study from a Korean research group appears to confirm the earlier findings.

SBRT in treatment of isolated, prostate cancer-specific metastases to bone

Stereotactic body radiation therapy (SBRT), most commonly carried out using the CyberKnife “robotic radiosurgery” technology, is already being used as first-line treatment for men with low- and intermediate-risk, localized prostate cancer, but it can also be used for highly targeted radiation of boney metastases.

A “last word” from the Genitourinary Cancers Symposium

Over 200 posters and other presentations of new data, as well as many other discussions and lectures, were offered yesterday in the prostate cancer sessions at the Genitourinary Cancers Symposium in Orlando.

4- and 5-year outcomes after SBRT for localized prostate cancer

Two posters presented today at the Genitourinary Cancers Symposium have extended our knowledge about outcomes after stereotactic body radiation therapy (SBRT or CyberKnife therapy) for localized disease.

Outcomes following EBRT and an SBRT “boost” for localized prostate cancer

New data from the radiotherapy group at the University of Califronia, San Francisco suggests that stereotactic body radiation (SBRT) can be used to deliver a “boost” of focused radiation after external beam radiation therapy (EBRT). High dose rate (HDR) brachytherapy has also been used in this way in the past.

5-year data on treatment of low-risk patients with SBRT

A new article in Radiation Oncology provides initial 5-year outcomes of patients treated with stereotactic body radiation therapy (SBRT), also known as CyberKnife therapy.

Data from a 300+ patient series treated with CyberKnife

Stereotactic body radiotherapy (SBRT) — aka CyberKnife radiotherapy — is among the most recent methods developed for the treatment of prostate cancer using radiation. People have been waiting a while now to see early data from a large series of patients.

Prostate cancer news reports: Thursday, February 18, 2010

Today’s news reports include commentary on studies dealing with: Whether RALP outcomes are really comparable to those from RRP Surgical expertise, surgical caseload, and pelvic lymphadenectomy in treatment of intermediate- and high-risk prostate cancer Sexual function after first-line treatment with SBRT (CyberKnife) Distinguishing true biochemical recurrence from a PSA “bounce” after 125I-based prostate brachytherapy

Stereotactic body radiation: early data from a trial of CyberKnife therapy

The ‘New” Prostate Cancer InfoLink has previously stated the importance of having more data about the potential of CyberKnife therapy in the treatment of localized prostate cancer. The first such data are now available.

Follow

Get every new post delivered to your Inbox.

Join 268 other followers